Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial. 1985

R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin

One hundred eighty-four patients were enrolled in a randomized study that evaluated the efficacy and toxicity of a single dose of orally administered cefuroxine axetil in the treatment of men and women with uncomplicated gonorrhea. Sixty-two patients received cefuroxine axetil alone, 62 received cefuroxine axetil and probenecid, and 60 received amoxicillin plus probenecid. Cure rates in the three groups were 98%, 98%, 96%, respectively. Only 2% of patients who received cefuroxine axetil alone complained of nausea, as compared with 11% of those who received a regimen that contained probenecid (P less than .05). The results show that cefuroxime axetil is effective and nontoxic in the treatment of uncomplicated gonococcal infections in adults.

UI MeSH Term Description Entries
D008297 Male Males
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
August 1986, Antimicrobial agents and chemotherapy,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
December 1988, Genitourinary medicine,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
December 1996, Antimicrobial agents and chemotherapy,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
February 1989, The Journal of antimicrobial chemotherapy,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
April 1991, The Pediatric infectious disease journal,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
November 1995, Journal of chemotherapy (Florence, Italy),
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
January 1994, Sexually transmitted diseases,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
January 1985, Sexually transmitted diseases,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
August 1989, Antimicrobial agents and chemotherapy,
R C Reichman, and F S Nolte, and S M Wolinsky, and C A Greisberger, and M A Trupei, and J Nitzkin
January 1987, Drugs under experimental and clinical research,
Copied contents to your clipboard!